Morrison & Foerster Secures Patent Infringement Victory for NeoGenomics in Cancer Test Kit Dispute with Natera
NeoGenomics, represented by Morrison & Foerster, wins a key patent infringement case against competitor Natera involving proprietary cancer diagnostic technology.
In a significant patent infringement ruling, Morrison & Foerster successfully defended NeoGenomics' proprietary cancer test kit technology against claims from rival Natera. The legal victory underscores the importance of robust intellectual property protection in the competitive oncology diagnostics market.